Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit that the Swiss pharma ...
In connection with Spark’s overhaul, Roche will incur approximately $2.4 billion in goodwill impairment costs. This sum takes ...
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...
Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
In a wide-ranging interview, Roche Group CEO Severin Schwan discusses his company's bid for Illumina, the future of gene-sequencing technology and what concerns him most about Europe's debt crisis.
which amplifies DNA or RNA from samples, layering in other diagnostic criteria like "colour, temperature, and data processing", according to Roche. The system uses five fluorescence channels with ...
We used T7 bacteriophage genomic DNA to demonstrate dual tagging and enrichment of fragments containing both tags (Fig. 2). We modified transposon ends to contain Roche/454-compatible tags (A and B).
Today, next-generation sequencing solutions from Roche play an important role in the sequencing ecosystem. Our KAPA sample preparation products offer high-performance DNA, RNA library prep and target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results